Vaxcyte
PCVX
PCVX
88 hedge funds and large institutions have $1.2B invested in Vaxcyte in 2022 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 36 increasing their positions, 22 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
more ownership
Funds ownership: →
1% more funds holding
Funds holding: 87 → 88 (+1)
9% more first-time investments, than exits
New positions opened: 12 | Existing positions closed: 11
Holders
88
Holding in Top 10
8
Calls
$751K
Puts
–
Top Buyers
| 1 | +$31M | |
| 2 | +$15.3M | |
| 3 | +$12.1M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$12M |
| 5 |
O
OrbiMed
New York
|
+$10.1M |
Top Sellers
| 1 | -$54.9M | |
| 2 | -$3.68M | |
| 3 | -$2.53M | |
| 4 |
WP
Woodline Partners
San Francisco,
California
|
-$2.32M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$883K |